how to switch from compounded semaglutide to wegovy Transition Branded Weight Loss Medications Switching from Tirzepatide to Semaglutide:

Gastrointestinal symptoms typically improve over time as the body adapts to the medication, though the timeframe varies between individuals

Abstract Tirzepatide, a dual agonist for glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptors, has shown robust efficacy in treating diabetes and obesity, and in obese patients with heart failure with preserved ejection fraction (HFpEF), it reduced weight, lowered blood pressure, and improved outcomes

Periorbital puffiness, the slight swelling around the eyes that accompanies inflammation and excess weight, resolves as systemic inflammation decreases

Claims that the compounded version contains the exact same active ingredient(s) in a manner that implies sameness to the brand-name product or approved sourcing